MedPath

Effect of 'Harmonizing Liver-spleen Method' for Laryngopharyngeal Reflux Disease and Influence on Intestinal Flora: A Randomized Controlled Clinical Trial

Not Applicable
Not yet recruiting
Conditions
aryngopharyngeal Reflux Disease
Registration Number
ITMCTR2200006616
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who match the diagnostic criteria of laryngopharyngeal reflux disease and TCM syndrome differentiation is liver and stomach disharmony.
2. Between 18 and 65 years old, male or female.
3. Patients should be informed consent, and volunteer to participate in the study.
4. Be able to complete relevant records such as case record form as required.

Exclusion Criteria

1. After this outbreak, other Chinese or Western medicines have been used to treat laryngopharyngeal reflux disease.
2. Pregnant women. If pregnant women are found during the study, the study will be suspended.
3. Unable to fully cooperate with the test and investigator due to intellectual or behavioral impairment.
4. Patients who are easily lost to follow-up due to frequent changes in working environment.
5. Suspected history of alcohol, antibiotics, hormones and other drug abuse.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.